tetradecanoylphorbol acetate has been researched along with piriprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobb, SM; McTiernan, R; Miller, AM | 1 |
| Boeynaems, JM; Flament, J; Schandene, L | 1 |
| Niwa, Y; Ohashi, T; Ozaki, Y | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and piriprost
| Article | Year |
|---|---|
Regulation of HL-60 differentiation by lipoxygenase pathway metabolites in vitro.
Topics: Caffeic Acids; Cell Adhesion; Cell Differentiation; Dimethyl Sulfoxide; Epoprostenol; Granulocytes; Histocytochemistry; Humans; In Vitro Techniques; Lipoxygenase Inhibitors; Monocytes; SRS-A; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured | 1990 |
Effect of the 5-lipoxygenase inhibitor piriprost on superoxide production by human neutrophils.
Topics: Arachidonate Lipoxygenases; Epoprostenol; Humans; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Superoxides; Tetradecanoylphorbol Acetate | 1988 |
A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Benzoquinones; Calcimycin; Chemotaxis, Leukocyte; Epoprostenol; Humans; Hydroxides; Hydroxyl Radical; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinones; Tetradecanoylphorbol Acetate; Umbelliferones | 1986 |